EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ADIL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -11.25
March 31, 2026 -1.476
December 31, 2025 -1.797
September 30, 2025 -2.022
June 30, 2025 -4.609
March 31, 2025 -0.3408
December 31, 2024 -7.996
September 30, 2024 -0.3756
June 30, 2024 -0.5877
March 31, 2024 -2.192
December 31, 2023 -1.154
September 30, 2023 -1.144
June 30, 2023 -1.392
March 31, 2023 -52.90
December 31, 2022 -1678.41
September 30, 2022 -1888.61
June 30, 2022 -98.89
March 31, 2022 -3.14
December 31, 2021 -7.101
September 30, 2021 -5.438
June 30, 2021 -6.312
Date Value
March 31, 2021 -7.594
December 31, 2020 -6.026
September 30, 2020 -6.111
June 30, 2020 -4.010
March 31, 2020 -5.422
December 31, 2019 -4.964
September 30, 2019 -4.184
June 30, 2019 -5.219
March 31, 2019 -8.128
December 31, 2018 -4.624
September 30, 2018 -36.92
June 30, 2018 -6.834
March 31, 2018 -1.393
December 31, 2017 -1.486
September 30, 2017 -1.076
June 30, 2017 -0.9718
March 31, 2017 -0.6565
December 31, 2016 -0.3512
September 30, 2016 -0.3802
June 30, 2016 -0.3518
March 31, 2016 -0.4618

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 7.939
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 2.268

EPS Diluted (Quarterly) Related Metrics